An acidic fusion partner strategy enabled high-level antimicrobial peptide expression from tandem gene constructs in E. coli, achieving practical yields for commercial antimicrobial peptide production.
Key findingAcidic partner-mediated tandem gene fusion in E. coli achieved high-level antimicrobial peptide expression with retained bioactivity after cleavage —
What the researchers found
Acidic partner-mediated tandem gene fusion in E. coli achieved high-level antimicrobial peptide expression with retained bioactivity after cleavage — a practical manufacturing approach for commercial-scale antimicrobial peptide production.
Why it matters
Relevant for antimicrobial-peptides, peptide-design.
How the study worked
in-vitro study.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2007.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
High-level expression of acidic partner-mediated antimicrobial peptide from tandem genes in Escherichia coli.
Applied biochemistry and biotechnology, 141(2-3), 203-13
Citation
Wang, Yun-Qi; Cai, Ji-Ye. (2007). High-level expression of acidic partner-mediated antimicrobial peptide from tandem genes in Escherichia coli.. Applied biochemistry and biotechnology, 141(2-3), 203-13.